Old Web
English
Sign In
Acemap
>
authorDetail
>
Chira Malmström
Chira Malmström
Orion Corporation
Androgen receptor
In vivo
Chemistry
CYP17A1
Biology
6
Papers
18
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
How to stop disproportionation of a hydrochloride salt of a very weakly basic compound in a non-clinical suspension formulation.
2021
International Journal of Pharmaceutics
Krista Ojala
Jukka Salmia
Anna Shevchenko
Johanna Ylikotila
Timo Korjamo
Bert van Veen
Piritta Koistinen
Chira Malmström
Sirpa Laakso
Indu Bansal
DS Samiulla
Anne Juppo
Show All
Source
Cite
Save
Citations (1)
Predicting the effect of prandial stage and particle size on absorption of ODM-204.
2020
European Journal of Pharmaceutics and Biopharmaceutics
Krista Ojala
Ronald Schilderink
Pirjo Nykänen
Bert van Veen
Chira Malmström
Anne Mari Juppo
Timo Korjamo
Show All
Source
Cite
Save
Citations (0)
ODM-204, a novel dual inhibitor of CYP17A1 and androgen receptor for the treatment of castration-resistant prostate cancer.
2016
Journal of Clinical Oncology
Pekka Kallio
Riikka Oksala
Anu Moilanen
Reetta Riikonen
Petteri Rummakko
Chira Malmström
Mika Mustonen
Show All
Source
Cite
Save
Citations (0)
1